Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martine Hoogendoorn (Rotterdam, Netherlands), Martine Hoogendoorn, Talitha Feenstra, Melinde Boland, Sixten Borg, Sven-Arne Jansson, Nancy Risebrough, Julia Slejko, Maureen Rutten-van Mölken. Prediction models for exacerbations in different COPD patient populations: Results of five large databases. Eur Respir J 2016; 48: Suppl. 60, 2006

Member's Comments

No comment yet.

Related content which might interest you: Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 COPD exacerbations and predictors in a general population Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Predictive factors for exacerbation and re-exacerbation in COPD: Results from the Swiss COPD cohort Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Costs of COPD exacerbations in a general population. Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 The predictors for COPD exacerbations using remote patient monitoring Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Compare clinical effectiveness of various types of bronchodilators in COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015